Endometrial cancer: a review and current management strategies: part I. (Q34423423)

2 August 2017

Endometrial cancer: a review and current management strategies: part I. (English)

1 reference

2 August 2017

1 reference

SGO Clinical Practice Endometrial Cancer Working Group

1

1 reference

2 August 2017

William M Burke

2

1 reference

2 August 2017

James Orr

3

1 reference

2 August 2017

Mario Leitao

4

1 reference

2 August 2017

Emery Salom

5

1 reference

2 August 2017

Paola Gehrig

6

1 reference

2 August 2017

Alexander B Olawaiye

7

1 reference

2 August 2017

Molly Brewer

8

1 reference

2 August 2017

Dave Boruta

9

1 reference

2 August 2017

Jeannine Villella

10

1 reference

2 August 2017

Tom Herzog

11

1 reference

2 August 2017

Fadi Abu Shahin

12

1 reference

2 August 2017

Society of Gynecologic Oncology Clinical Practice Committee

13

1 reference

2 August 2017

language of work or name

English

0 references

publication date

4 June 2014

1 reference

2 August 2017

1 reference

2 August 2017

134

1 reference

2 August 2017

2

1 reference

2 August 2017

385-392

1 reference

2 August 2017

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

The epidemic of endometrial cancer: a commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Estrogen-progestin replacement therapy and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Association between adiponectin, insulin resistance, and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Hypertension and Hormone-Related Neoplasms in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Risk factors for young premenopausal women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Cigarette smoking and the risk of endometrial cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

PTEN: one gene, many syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Risk of Endometrial Carcinoma Associated with BRCA Mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Computed tomography in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Laparoscopically assisted surgical staging (LASS) of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Laparoscopic bilateral pelvic and paraaortic lymph node sampling: an evolving technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Low incidence of port-site metastases after laparoscopic staging of uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Vaginal hysterectomy versus abdominal hysterectomy for the treatment of stage I endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Lymph node sampling and survival in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Surgical cytoreduction in stage IV endometrioid endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Surgical stage IV endometrial carcinoma: a study of 47 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Surgical treatment of recurrent endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Salvage cytoreductive surgery for recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

Pelvic exenteration for recurrent endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.05.018

10.1016/J.YGYNO.2014.05.018

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference